Belden Q2 Adjusted EPS USD 2.34 Vs. IBES Estimate USD 2.02
BDC•Belden reports second-quarter results
Jul 30 (Reuters) - Belden Q2 revenue USD 750 million vs. IBES estimate USD 746.7 million.
- Q2 adjusted EBITDA USD 146 million
- Q2 adjusted EBITDA margin 19.5%
- Q2 EPS USD 1.74
Related News

Century Casinos updates financial calendar with Q2 earnings release, conference call schedule
CNTY•

Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026
APRE•


